Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients
This study is currently recruiting participants.
Verified December 2011 by Instituto Valenciano de Infertilidad, Spain
Sponsor:
Instituto Valenciano de Infertilidad, Spain
Information provided by (Responsible Party):
Instituto Valenciano de Infertilidad, Spain
ClinicalTrials.gov Identifier:
NCT01501448
First received: December 27, 2011
Last updated: December 29, 2011
Last verified: December 2011
| Tracking Information | |||||
|---|---|---|---|---|---|
| First Received Date ICMJE | December 27, 2011 | ||||
| Last Updated Date | December 29, 2011 | ||||
| Start Date ICMJE | June 2011 | ||||
| Estimated Primary Completion Date | January 2012 (final data collection date for primary outcome measure) | ||||
| Current Primary Outcome Measures ICMJE |
Implantation rate [ Time Frame: 20 days after the embryo transfer ] [ Designated as safety issue: No ] number of embryonic sacs visible by ultrasound divided by the number of embryos transferred |
||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||
| Change History | Complete list of historical versions of study NCT01501448 on ClinicalTrials.gov Archive Site | ||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||
| Descriptive Information | |||||
| Brief Title ICMJE | Oral Estradiol Valerate Versus Oral Contraceptive Pill in Invitro Fertilization Patients | ||||
| Official Title ICMJE | Not Provided | ||||
| Brief Summary | The recent controversy regarding the use of pill for cycle planning in GnRH antagonists IVF cycle has driven the search for new ways to plan IVF cycles in order to avoid weekends or to equally distribute the workload. Recently, mid-late luteal phase oral estrogens seem to be as good as the pill. The investigators will compare OCP vs oral estrogens to plan the initiation of IVF cycles. |
||||
| Detailed Description | Not Provided | ||||
| Study Type ICMJE | Interventional | ||||
| Study Phase | Phase 4 | ||||
| Study Design ICMJE | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment |
||||
| Condition ICMJE | Infertility | ||||
| Intervention ICMJE |
|
||||
| Study Arm (s) |
|
||||
| Publications * | Not Provided | ||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||
| Recruitment Information | |||||
| Recruitment Status ICMJE | Recruiting | ||||
| Estimated Enrollment ICMJE | 100 | ||||
| Estimated Completion Date | April 2012 | ||||
| Estimated Primary Completion Date | January 2012 (final data collection date for primary outcome measure) | ||||
| Eligibility Criteria ICMJE | Inclusion Criteria:
Exclusion Criteria:
|
||||
| Gender | Female | ||||
| Ages | 18 Years to 38 Years | ||||
| Accepts Healthy Volunteers | No | ||||
| Contacts ICMJE |
|
||||
| Location Countries ICMJE | Spain | ||||
| Administrative Information | |||||
| NCT Number ICMJE | NCT01501448 | ||||
| Other Study ID Numbers ICMJE | IVIMAD-GV-OCPE-2011 | ||||
| Has Data Monitoring Committee | Not Provided | ||||
| Responsible Party | Instituto Valenciano de Infertilidad, Spain | ||||
| Study Sponsor ICMJE | Instituto Valenciano de Infertilidad, Spain | ||||
| Collaborators ICMJE | Not Provided | ||||
| Investigators ICMJE | Not Provided | ||||
| Information Provided By | Instituto Valenciano de Infertilidad, Spain | ||||
| Verification Date | December 2011 | ||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||